Members
![]() | First name: Emmanuelle Last name: Papot Function: Project Manager Position: MD Email: emmanuelle.papot inserm.fr |
Research interest
Education
Degree
2015 : MSc in Public Health, London School of Hygiene and Tropical Medicine, United Kingdom
2008 : Diploma in Retrovirology, Saint Denis Cayenne University, French Guiana
2008 : Post-Graduate Diploma in Tropical Medicine, Victor Segalen Bordeaux II University, France
2007 : M.D., qualification in general medicine, Victor Segalen Bordeaux II University, France
2002 : Second cycle of medical studies, Victor Segalen Bordeaux II University, France
2008 : Diploma in Retrovirology, Saint Denis Cayenne University, French Guiana
2008 : Post-Graduate Diploma in Tropical Medicine, Victor Segalen Bordeaux II University, France
2007 : M.D., qualification in general medicine, Victor Segalen Bordeaux II University, France
2002 : Second cycle of medical studies, Victor Segalen Bordeaux II University, France
Exhaustive list of publications
2022
Cortier M, de La Porte C, Papot E, Goudjo A, Guenneau L, Riou F, Cervantes-Gonzalez M, Prioux M, Yazdanpanah Y, Galy A
Health status and healthcare trajectory of vulnerable asylum seekers hosted in a French Reception Center.
Travel Medicine and Infectious Disease 2022, 46, 102180.
2021
Papot E, Kalampalikis N, Doumergue M, Pilorgé F, Quatremère G, Yazdanpanah Y, Préau M, AGsg
Can we talk about price with patients when choosing antiretroviral therapy? A survey with people living with HIV and prescribers in France.
BMJ open 2021, 11, e046212.
2020
Couffignal C, Papot E, Etienne A, Legac S, Laouénan C, Beres D, Blum L, Khuong-Josses MA, Lepretre A, Papazian P, Yazdanpanah Y, Bouvet E
Treatment as prevention (TasP) and perceived sexual changes in behavior among HIV-positive persons: a French survey in infectious diseases departments in Paris.
AIDS care 2020, 32, 811-817.
Fournier AL, Parienti JJ, Champenois K, Feret P, Papot E, Yazdanpanah Y, Verdon R
Incidence and risk factors for medical care interruption in people living with HIV in a French provincial city.
PloS One 2020, 15, e0240417.
2019
Pommier JD, Laouénan C, Michard F, Papot E, Urios P, Boutten A, Peytavin G, Ghander C, Lariven S, Castanedo G, Moho D, Landman R, Phung B, Perez E, Julia Z, Descamps D, Roland-Nicaise P, Le Gac S, Yazdanpanah Y, Guibourdenche J, Yeni P
Metabolic syndrome and endocrine status in HIV-infected transwomen.
AIDS (London, England) 2019, 33, 855-865.
Fournier AL, Yazdanpanah Y, Verdon R, Lariven S, Mackoumbou-Nkouka C, Phung BC, Papot E, Parienti JJ, Landman R, Champenois K, Yotebieng M
Incidence of and risk factors for medical care interruption in people living with HIV in recent years.
PLOS ONE 2019, 14, e0213526.
2017
Papot E, Landman R, Louni F, Charpentier C, Peytavin G, Certain A, Fradet C, Castro DR, Preau M, Goujard C, Yeni P, Yazdanpanah Y, AGSG
Budget impact of antiretroviral therapy in a French clinic cohort.
AIDS (London, England) 2017, 31, 1271-1279.
2016
Delory T, Papot E, Rioux C, Charpentier C, Auge-Courtoi C, Michard F, Peytavin G, Descamps D, Matheron S, Yazdanpanah Y
Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.
Journal of Medical Virology 2016, 88, 1204-1210.
2015
Ferrand H, Blanc-Gruyelle AL, Amsilli M, Lemaire X, Papot E, Papy E, Bervar J, Senneville E, Bouvet E, Yazdanpanah Y
Use of fluoroquinolones for the treatment of TB: 8 years of experience.
The Journal of Antimicrobial Chemotherapy 2015, 70, 3166-3167.